Epigenomics AG (Epigenomics AG) ROE % Adjusted to Book Value : -220.98% (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Epigenomics AG ROE % Adjusted to Book Value?

Epigenomics AG's ROE % for the quarter that ended in Jun. 2023 was -329.26%. Epigenomics AG's PB Ratio for the quarter that ended in Jun. 2023 was 1.49. Epigenomics AG's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was -220.98%.

Epigenomics AG ROE % Adjusted to Book Value Historical Data

The historical data trend for Epigenomics AG's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigenomics AG ROE % Adjusted to Book Value Chart

Epigenomics AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-26.37

-18.31

-33.76

-42.00

-106.30

Epigenomics AG Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-79.08	-93.69	-334.93	-510.35	-220.98

Competitive Comparison of Epigenomics AG's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Epigenomics AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Epigenomics AG's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Epigenomics AG's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Epigenomics AG's ROE % Adjusted to Book Value falls into.

Epigenomics AG ROE % Adjusted to Book Value Calculation

Epigenomics AG's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-71.22%	/	0.67
	=	-106.30%

Epigenomics AG's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-329.26%	/	1.49
	=	-220.98%

Epigenomics AG ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Epigenomics AG's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Epigenomics AG (Epigenomics AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Epigenomics AG (OTCPK:EPGNF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ECX:Germany

Address

Geneststrasse 5, Berlin, BB, DEU, 10829

Website

https://www.epigenomics.com

Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.

Epigenomics AG (Epigenomics AG) Headlines

From GuruFocus

Encode Ideas, L.P. to host Virtual 1x1 Webinar with Epigenomics AG (ECX.DE, EPGNF) on Tuesday, July 28th at 10:30 AM ET

By ACCESSWIRE ACCESSWIRE • 07-23-2020